Helix BioPharma names Karen Krumeich board chair, adds three directors

Karen Krumeich was named board chair and audit committee chair, effective Sept. 28, 2026. Jamieson Bondarenko, Charmaine Lykins and Dirk Brockstedt joined the board; Jacek Antas, Malgorzata Laube and Jerzy Leszczynski resigned.